Qiagen NVXTER:QIA +4.28%69 Dividend Yield % is 0.66% as of Jun. 25, 2026, which is 20% above its 10-year median of 0.55. GuruFocus rates XTER:QIA with a GF Score™ of 69/100 and a GF Value™ of €46.28 (Modestly Undervalued). The stock has 2 warning signs investors should review. Among 65 Medical Diagnostics & Research companies, Qiagen NV ranks worse than 83.08% on this metric.
As of today (2026-06-25), the Trailing Annual Dividend Yield of Qiagen NV is 0.66%.
The historical rank and industry rank for Qiagen NV's Dividend Yield % or its related term are showing as below:
XTER:QIA'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.47 Med: 0.55 Max: 0.8
Current: 0.66
During the past 13 years, the highest Dividend Yield of Qiagen NV was 0.80%. The lowest was 0.47%. And the median was 0.55%.
XTER:QIA's Dividend Yield % is ranked worse than 83.08% of 65
companies
in the Medical Diagnostics & Research industry
Industry Median: 2.02
vs XTER:QIA: 0.66
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
Qiagen NV (XTER:QIA) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
The historical data trend for Qiagen NV's Dividend Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
XTER:QIA vs CRL, ICLR, BLLN: Dividend Yield % Comparison
For the Diagnostics & Research subindustry, Qiagen NV's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
Qiagen NV Dividend Yield % vs Medical Diagnostics & Research Industry
For the Medical Diagnostics & Research industry and Healthcare sector, Qiagen NV's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where Qiagen NV's Dividend Yield % falls into.
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
Qiagen NV Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
USD 0.263158
2025-07-02
2025-07-02
2025-07-10
Cash Dividend
annually
USD:EUR 0.857000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
Qiagen NV's Trailing Annual Dividend Yield (%) for Today is calculated as
Trailing Annual Dividend Yield
=
Most Recent Full Year Dividend
/
Current Share Price
=
0.225526406
/
34.005
=
0.66 %
Current Share Price is €34.005. Qiagen NV's Dividends per Share for the trailing twelve months (TTM) ended in Today is €0.225526406.
Qiagen NV's Forward Annual Dividend Yield (%) for Today is calculated as
Forward Annual Dividend Yield
=
Forward Full Year Dividend
/
Current Share Price
=
0.225526406
/
34.005
=
0.66 %
Current Share Price is €34.005. Qiagen NV's Dividends per Share for the forward twelve months is calculated as €0.225526406 * 1 = €0.225526406.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
Qiagen NV (XTER:QIA) has a Dividend Yield % of 0.66% as of Jun. 25, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on Qiagen NV and its competitors. This is 20% above median its historical median of 0.55. Over the past decade, Qiagen NV's Dividend Yield % has ranged from 0.47 to 0.80. According to the industry distribution chart, Qiagen NV ranks #54 out of 65 companies in the Medical Diagnostics & Research industry, placing it in the top 83.1%.
Is Qiagen NV's Dividend Yield % too high?
Qiagen NV's current Dividend Yield % of 0.66% is 20% above median its 10-year median of 0.55. Over the past 10 years, this metric has ranged from a low of 0.47 to a high of 0.80. The Medical Diagnostics & Research industry median Dividend Yield % is 2.02. Qiagen NV's value of 0.66% is 67.3% below this industry median. Based on the distribution chart, Qiagen NV ranks #54 out of 65 companies in the Medical Diagnostics & Research industry, which is in the bottom quartile relative to peers. Overall, Qiagen NV has a GF Score™ of 69/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Qiagen NV's Dividend Yield % compare to CRL and ICLR?
According to the Medical Diagnostics & Research industry distribution chart, Qiagen NV ranks #54 out of 65 companies for Dividend Yield %. This places Qiagen NV in the lower half of its industry. The industry median Dividend Yield % is 2.02. Qiagen NV's value of 0.66% is 67.3% below this benchmark. Historically, Qiagen NV's own Dividend Yield % has ranged from 0.47 to 0.80 over the past decade. While the company's 10-year median is 0.55 vs. the industry median of 2.02, Qiagen NV has consistently been below the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Medical Diagnostics & Research company?
The median Dividend Yield % among Medical Diagnostics & Research companies is 2.02, based on 65 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Qiagen NV's current Dividend Yield % of 0.66% is 67.3% below the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on Qiagen NV and its competitors. For the Medical Diagnostics & Research industry, the median Dividend Yield % is 2.02 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. Qiagen NV's current Dividend Yield % is 0.66%, which is 20% above median its own 10-year median of 0.55. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Qiagen NV stock overvalued right now?
Based on GuruFocus' analysis, Qiagen NV (XTER:QIA) is currently considered Modestly Undervalued. The stock's GF Value™ is €46.28, compared to a current price of €34.01 — trading 26.5% below its estimated fair value. The current Dividend Yield % is 0.66%, which is 20% above median its 10-year median of 0.55 and 67.3% below the Medical Diagnostics & Research industry median of 2.02. Qiagen NV's overall GF Score™ is 69/100 with 2 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For Qiagen NV (XTER:QIA), the current Dividend Yield % is 0.66% as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is Qiagen NV (XTER:QIA) Overvalued in 2026?
Based on GuruFocus' analysis, Qiagen NV stock appears to be undervalued.
The current stock price of €34.01 is trading 26.5% below its estimated GF Value™ of €46.28.
GuruFocus considers Qiagen NV to be Modestly Undervalued.
Key valuation signals for XTER:QIA:
Dividend Yield %: 0.66% (20% above median its 10-year median of 0.55)
GF Value™: €46.28 vs. price of €34.01 (26.5% below fair value)
Industry Position: 67.3% below the Medical Diagnostics & Research median (#54 of 65)
No single metric tells the full story. See the XTER:QIA stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
Qiagen offers proprietary sample and assay technology to extract, purify, amplify, and interpret DNA, RNA, and proteins. The company's sales are split almost evenly between applications in life sciences and molecular diagnostics. Qiagen generates nearly 90% of its revenue from consumables with the balance coming from instrumentation and related services. The Americas account for the largest portion of the firm's revenue (52% of 2024 sales), followed by EMEA (33%), and the Asia-Pacific (15%).
69GF Score
Get the complete analysis for XTER:QIA
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
XTER:QIA has been successfully added to your 
